Please read and agree to the
terms and conditions
of this site.
I agree
Medical Technology
/tech
Clear filters and search
Format
photo
3
×
Tags
type 1 diabetes
3
×
biotech
clinical trials
diabetes
indiana blog main
indiana top stories
life sciences
national blog main
new york blog main
new york top stories
abeona therapeutics
accent therapeutics
achilles therapeutics
akouos
alder biopharmaceuticals
alexion pharmaceuticals
alnylam pharmaceuticals
alopecia areata
amarin
american diabetes association
amgen
aridis pharmaceuticals
aristea therapeutics
artificial intelligence
autoimmune diseases
axitinib
bellus health
biotech ipos
blood sugar
boehringer ingelheim
bolt biotherapeutics
boston blog main
boston top stories
boulder/denver blog main
boulder/denver top stories
bridgebio
bristol-myers squibb
cancer
cell therapy
cidara therapeutics
What
patients
type
3
×
diabetes
drug
advantages
approval
bar
bid
bio
boehringer
brings
catch
catching
earlier
early
eli
expand
expect
fallen
fda
gamble
ibm's
identify
ingelheim
key
lilly
market
marketed
medco’s
medicine’s
mover
new
payers
physicians
plan
pricing
rejects
risk
roundup
sets
Language
unset
Current search:
type
×
photo
×
" type 1 diabetes "
×
@xconomy.com
4 years ago
FDA Rejects Boehringer Ingelheim, Eli Lilly Drug for Type 1 Diabetes
@xconomy.com
4 years ago
Bio Roundup: MedCo’s Pricing Plan, Vertex’s Gamble, uBiome Undone
@engadget.com
4 years ago
AI could be the key to catching Type 1 diabetes much earlier